BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 8769642)

  • 1. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation.
    Clurman BE; Sheaff RJ; Thress K; Groudine M; Roberts JM
    Genes Dev; 1996 Aug; 10(16):1979-90. PubMed ID: 8769642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells.
    Tintignac LA; Leibovitch MP; Kitzmann M; Fernandez A; Ducommun B; Meijer L; Leibovitch SA
    Exp Cell Res; 2000 Aug; 259(1):300-7. PubMed ID: 10942602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome.
    Nguyen H; Gitig DM; Koff A
    Mol Cell Biol; 1999 Feb; 19(2):1190-201. PubMed ID: 9891053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
    Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM; Dickson RB
    Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.
    Diehl JA; Zindy F; Sherr CJ
    Genes Dev; 1997 Apr; 11(8):957-72. PubMed ID: 9136925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 May; 18(21):3290-302. PubMed ID: 10359535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins.
    Zariwala M; Liu J; Xiong Y
    Oncogene; 1998 Nov; 17(21):2787-98. PubMed ID: 9840943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E.
    Won KA; Reed SI
    EMBO J; 1996 Aug; 15(16):4182-93. PubMed ID: 8861947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of proteasomes in T cell activation and proliferation.
    Wang X; Luo H; Chen H; Duguid W; Wu J
    J Immunol; 1998 Jan; 160(2):788-801. PubMed ID: 9551914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of bovine papillomavirus replicative helicase e1 by the ubiquitin-proteasome pathway.
    Malcles MH; Cueille N; Mechali F; Coux O; Bonne-Andrea C
    J Virol; 2002 Nov; 76(22):11350-8. PubMed ID: 12388695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway.
    Rousseau D; Cannella D; Boulaire J; Fitzgerald P; Fotedar A; Fotedar R
    Oncogene; 1999 Jul; 18(30):4313-25. PubMed ID: 10439039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between cyclin T1 and SCF(SKP2) targets CDK9 for ubiquitination and degradation by the proteasome.
    Kiernan RE; Emiliani S; Nakayama K; Castro A; Labbé JC; Lorca T; Nakayama Ki K; Benkirane M
    Mol Cell Biol; 2001 Dec; 21(23):7956-70. PubMed ID: 11689688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triggering ubiquitination of a CDK inhibitor at origins of DNA replication.
    Furstenthal L; Swanson C; Kaiser BK; Eldridge AG; Jackson PK
    Nat Cell Biol; 2001 Aug; 3(8):715-22. PubMed ID: 11483956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyposmotic stress induces cell growth arrest via proteasome activation and cyclin/cyclin-dependent kinase degradation.
    Tao GZ; Rott LS; Lowe AW; Omary MB
    J Biol Chem; 2002 May; 277(22):19295-303. PubMed ID: 11897780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes.
    Dulić V; Drullinger LF; Lees E; Reed SI; Stein GH
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11034-8. PubMed ID: 8248208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin E-CDK2 is a regulator of p27Kip1.
    Sheaff RJ; Groudine M; Gordon M; Roberts JM; Clurman BE
    Genes Dev; 1997 Jun; 11(11):1464-78. PubMed ID: 9192873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteasome-mediated degradation of BRCA1 protein in MCF-7 human breast cancer cells.
    Choi YH
    Int J Oncol; 2001 Oct; 19(4):687-93. PubMed ID: 11562742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell cycle. Order from destruction.
    Bartek J; Lukas J
    Science; 2001 Oct; 294(5540):66-7. PubMed ID: 11588240
    [No Abstract]   [Full Text] [Related]  

  • 20. The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCF(Skp2).
    Tedesco D; Lukas J; Reed SI
    Genes Dev; 2002 Nov; 16(22):2946-57. PubMed ID: 12435635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.